{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:12:38Z","timestamp":1790871158294,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31972662"],"award-info":[{"award-number":["31972662"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research and Development Project","award":["2017YFD0500702"],"award-info":[{"award-number":["2017YFD0500702"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) is a major antigen that can induce protective antibodies in poultry. However, its antigenic epitopes have not been fully elucidated. Therefore, defining the linear epitopes of HN, especially neutralizing epitopes, will be useful for revealing its antigenic characterization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we analyzed B-cell immunodominant epitopes (IDEs) of the HN protein from the vaccine strain LaSota using pepscan technology with LaSota-specific chicken hyperimmune antisera. We constructed IDEs-RFP plasmids and prepared anti-IDEs peptide mouse sera to identify IDEs through immunological tests. At last, the different diluted anti-IDE antisera were used in BHK-21 cells to perform the neutralization test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five IDEs of the HN were screened and further verified by indirect immunofluorescence assays, dot blots and Western blots with NDV- and IDEs-specific antisera. All five IDEs showed good immunogenicity. IDE5 (328\u2013342 aa) could recognize only class II NDV but did not react with the class I strain. Most of the IDEs are highly conserved among the different strains. A neutralization test in vitro showed that the peptide-specific mouse antisera of IDE4 (242\u2013256 aa) and HN341-355, a reported neutralizing linear epitope, could partially neutralize avirulent LaSota as well as virulent strains at similar levels, suggesting that IDE4 might be a potential neutralizing linear epitope.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The HN protein is a major protective antigen of NDV that can induce neutralizing antibodies in animals. We identified five IDEs of the HN using a pepscan approach with NDV-specific chicken hyperimmune antisera. The five IDEs could elicit specific antibodies in mice. IDE4 (242\u2013256 aa) was identified as a novel potential neutralizing linear epitope. These results will help elucidate the antigenic epitopes of the HN and facilitate the development of NDV vaccines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-020-01483-y","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T17:03:49Z","timestamp":1609952629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus"],"prefix":"10.1186","volume":"18","author":[{"given":"Zhongyuan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaolin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youkun","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujing","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3444-7241","authenticated-orcid":false,"given":"Sa","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"2","key":"1483_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/03079450120044515","volume":"30","author":"EW Aldous","year":"2001","unstructured":"Aldous EW, Alexander DJ. Detection and differentiation of Newcastle disease virus (avian paramyxovirus type 1). Avian Pathol. 2001;30(2):117\u201328.","journal-title":"Avian Pathol"},{"issue":"22","key":"1483_CR2","doi-asserted-by":"publisher","first-page":"12641","DOI":"10.1128\/JVI.00843-07","volume":"81","author":"LM Kim","year":"2007","unstructured":"Kim LM, King DJ, Curry PE, Suarez DL, Swayne DE, Stallknecht DE, et al. Phylogenetic diversity among low-virulence newcastle disease viruses from waterfowl and shorebirds and comparison of genotype distributions to those of poultry-origin isolates. J Virol. 2007;81(22):12641\u201353.","journal-title":"J Virol"},{"issue":"Pt 1","key":"1483_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1099\/0022-1317-80-1-131","volume":"80","author":"O de Leeuw","year":"1999","unstructured":"de Leeuw O, Peeters B. Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J Gen Virol. 1999;80(Pt 1):131\u20136.","journal-title":"J Gen Virol"},{"key":"1483_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.virusres.2014.02.016","volume":"184","author":"K Ganar","year":"2014","unstructured":"Ganar K, Das M, Sinha S, Kumar S. Newcastle disease virus: current status and our understanding. Virus Res. 2014;184:71\u201381.","journal-title":"Virus Res"},{"issue":"Pt 12","key":"1483_CR5","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1099\/0022-1317-74-12-2539","volume":"74","author":"M Steward","year":"1993","unstructured":"Steward M, Vipond IB, Millar NS, Emmerson PT. RNA editing in Newcastle disease virus. J Gen Virol. 1993;74(Pt 12):2539\u201347.","journal-title":"J Gen Virol"},{"issue":"6120","key":"1483_CR6","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1126\/science.1230949","volume":"339","author":"C Motz","year":"2013","unstructured":"Motz C, Schuhmann KM, Kirchhofer A, Moldt M, Witte G, Conzelmann KK, et al. Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science. 2013;339(6120):690\u20133.","journal-title":"Science"},{"issue":"8","key":"1483_CR7","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1128\/JVI.78.8.4176-4184.2004","volume":"78","author":"Z Huang","year":"2004","unstructured":"Huang Z, Panda A, Elankumaran S, Govindarajan D, Rockemann DD, Samal SK. The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence. J Virol. 2004;78(8):4176\u201384.","journal-title":"J Virol"},{"issue":"Pt 7","key":"1483_CR8","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1099\/vir.0.79877-0","volume":"85","author":"L Ferreira","year":"2004","unstructured":"Ferreira L, Munoz-Barroso I, Marcos F, Shnyrov VL, Villar E. Sialidase, receptor-binding and fusion-promotion activities of Newcastle disease virus haemagglutinin-neuraminidase glycoprotein: a mutational and kinetic study. J Gen Virol. 2004;85(Pt 7):1981\u20138.","journal-title":"J Gen Virol"},{"issue":"23","key":"1483_CR9","doi-asserted-by":"publisher","first-page":"13053","DOI":"10.1128\/JVI.78.23.13053-13061.2004","volume":"78","author":"VR Melanson","year":"2004","unstructured":"Melanson VR, Iorio RM. Amino acid substitutions in the F-specific domain in the stalk of the newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein. J Virol. 2004;78(23):13053\u201361.","journal-title":"J Virol"},{"key":"1483_CR10","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3389\/fmicb.2017.01607","volume":"8","author":"JH Jin","year":"2017","unstructured":"Jin JH, Cheng JL, He ZR, Ren YC, Yu XH, Song Y, et al. Different origins of newcastle disease virus hemagglutinin-neuraminidase protein modulate the replication efficiency and pathogenicity of the virus. Front Microbiol. 2017;8:1607.","journal-title":"Front Microbiol"},{"issue":"11","key":"1483_CR11","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/81002","volume":"7","author":"S Crennell","year":"2000","unstructured":"Crennell S, Takimoto T, Portner A, Taylor G. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol. 2000;7(11):1068\u201374.","journal-title":"Nat Struct Biol"},{"issue":"11","key":"1483_CR12","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.1128\/JVI.00188-09","volume":"83","author":"Y Yan","year":"2009","unstructured":"Yan Y, Rout SN, Kim SH, Samal SK. Role of untranslated regions of the hemagglutinin-neuraminidase gene in replication and pathogenicity of Newcastle disease virus. J Virol. 2009;83(11):5943\u20136.","journal-title":"J Virol"},{"issue":"19","key":"1483_CR13","doi-asserted-by":"publisher","first-page":"10250","DOI":"10.1128\/JVI.01038-09","volume":"83","author":"SH Kim","year":"2009","unstructured":"Kim SH, Yan Y, Samal SK. Role of the cytoplasmic tail amino acid sequences of Newcastle disease virus hemagglutinin-neuraminidase protein in virion incorporation, cell fusion, and pathogenicity. J Virol. 2009;83(19):10250\u20135.","journal-title":"J Virol"},{"issue":"2","key":"1483_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/JVI.48.2.440-450.1983","volume":"48","author":"RM Iorio","year":"1983","unstructured":"Iorio RM, Bratt MA. Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein. J Virol. 1983;48(2):440\u201350.","journal-title":"J Virol"},{"issue":"3","key":"1483_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0168-1702(89)90019-1","volume":"13","author":"RM Iorio","year":"1989","unstructured":"Iorio RM, Glickman RL, Riel AM, Sheehan JP, Bratt MA. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment. Virus Res. 1989;13(3):245\u201361.","journal-title":"Virus Res"},{"issue":"Pt 8","key":"1483_CR16","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1099\/0022-1317-69-8-2115","volume":"69","author":"P Chambers","year":"1988","unstructured":"Chambers P, Nesbit M, Yusoff K, Millar NS, Samson AC, Emmerson PT. Location of a neutralizing epitope for the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J Gen Virol. 1988;69(Pt 8):2115\u201322.","journal-title":"J Gen Virol"},{"key":"1483_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2013.10.016","volume":"101","author":"K Li","year":"2014","unstructured":"Li K, Gao L, Gao H, Qi X, Gao Y, Qin L, et al. Recombinant infectious bursal disease virus expressing Newcastle disease virus (NDV) neutralizing epitope confers partial protection against virulent NDV challenge in chickens. Antivir Res. 2014;101:1\u201311.","journal-title":"Antivir Res"},{"issue":"6","key":"1483_CR18","doi-asserted-by":"publisher","first-page":"e0131723","DOI":"10.1371\/journal.pone.0131723","volume":"10","author":"T Li","year":"2015","unstructured":"Li T, Wang G, Shi B, Liu P, Si W, Wang B, et al. Comprehensive analysis and characterization of linear antigenic domains on HN protein from genotype VII Newcastle disease virus using yeast surface display system. PLoS ONE. 2015;10(6):e0131723.","journal-title":"PLoS ONE"},{"key":"1483_CR19","first-page":"293","volume":"17","author":"LD Loomis-Price","year":"1999","unstructured":"Loomis-Price LD. Linear epitope mapping by the PEPSCAN method. Methods Mol Med. 1999;17:293\u2013307.","journal-title":"Methods Mol Med"},{"issue":"1\u20132","key":"1483_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jim.2004.11.018","volume":"299","author":"Q Gaofu","year":"2005","unstructured":"Gaofu Q, Jie L, Rongyue C, Xin Y, Dan M, Jie W, et al. Asparaginase display of polypeptides in the periplasm of Escherichia coli: potential rapid pepscan technique for antigen epitope mapping. J Immunol Methods. 2005;299(1\u20132):9\u201319.","journal-title":"J Immunol Methods"},{"issue":"2","key":"1483_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s11262-013-0943-x","volume":"47","author":"S Zhao","year":"2013","unstructured":"Zhao S, Qi T, Guo W, Lu G, Xiang W. Identification of a conserved B-cell epitope in the equine arteritis virus (EAV) N protein using the pepscan technique. Virus Genes. 2013;47(2):292\u20137.","journal-title":"Virus Genes"},{"issue":"3\u20134","key":"1483_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.vetmic.2014.09.004","volume":"174","author":"X Wang","year":"2014","unstructured":"Wang X, Qui L, Dang Y, Xiao S, Zhang S, Yang Z. Linear epitope recognition antibodies strongly respond to the C-terminal domain of HP-PRRSV GP5. Vet Microbiol. 2014;174(3\u20134):565\u20139.","journal-title":"Vet Microbiol"},{"issue":"5","key":"1483_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1089\/vim.2019.0007","volume":"32","author":"Y Bi","year":"2019","unstructured":"Bi Y, Jin Z, Wang Y, Mou S, Wang W, Wei Q, et al. Identification of two distinct linear B cell epitopes of the matrix protein of the Newcastle disease virus vaccine strain LaSota. Viral Immunol. 2019;32(5):221\u20139.","journal-title":"Viral Immunol"},{"issue":"24","key":"1483_CR24","doi-asserted-by":"publisher","first-page":"e01499","DOI":"10.1128\/JVI.01499-19","volume":"93","author":"W Wang","year":"2019","unstructured":"Wang W, Chang X, Yao W, Wei N, Huo N, Wang Y, et al. Host CARD11 inhibits Newcastle disease virus replication by suppressing viral polymerase activity in neurons. J Virol. 2019;93(24):e01499.","journal-title":"J Virol"},{"issue":"Pt 5","key":"1483_CR25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1099\/0022-1317-71-5-1189","volume":"71","author":"Y Umino","year":"1990","unstructured":"Umino Y, Kohama T, Sato TA, Sugiura A, Klenk HD, Rott R. Monoclonal antibodies to three structural proteins of Newcastle disease virus: biological characterization with particular reference to the conformational change of envelope glycoproteins associated with proteolytic cleavage. J Gen Virol. 1990;71(Pt 5):1189\u201397.","journal-title":"J Gen Virol"},{"issue":"1","key":"1483_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0042-6822(90)90408-J","volume":"178","author":"ME Boursnell","year":"1990","unstructured":"Boursnell ME, Green PF, Samson AC, Campbell JI, Deuter A, Peters RW, et al. A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology. 1990;178(1):297\u2013300.","journal-title":"Virology"},{"issue":"2","key":"1483_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1128\/JVI.51.2.445-451.1984","volume":"51","author":"RM Iorio","year":"1984","unstructured":"Iorio RM, Bratt MA. Neutralization of Newcastle disease virus by monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization. J Virol. 1984;51(2):445\u201351.","journal-title":"J Virol"},{"issue":"12","key":"1483_CR28","doi-asserted-by":"publisher","first-page":"6913","DOI":"10.1128\/JVI.77.12.6913-6922.2003","volume":"77","author":"EA Corey","year":"2003","unstructured":"Corey EA, Mirza AM, Levandowsky E, Iorio RM. Fusion deficiency induced by mutations at the dimer interface in the Newcastle disease virus hemagglutinin-neuraminidase is due to a temperature-dependent defect in receptor binding. J Virol. 2003;77(12):6913\u201322.","journal-title":"J Virol"},{"issue":"11","key":"1483_CR29","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1128\/JVI.62.11.4427-4430.1988","volume":"62","author":"T Toyoda","year":"1988","unstructured":"Toyoda T, Gotoh B, Sakaguchi T, Kida H, Nagai Y. Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. J Virol. 1988;62(11):4427\u201330.","journal-title":"J Virol"},{"issue":"1\u20132","key":"1483_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF01313728","volume":"94","author":"Y Umino","year":"1987","unstructured":"Umino Y, Kohama T, Kohase M, Sugiura A, Klenk HD, Rott R. Protective effect of antibodies to two viral envelope glycoproteins on lethal infection with Newcastle disease virus. Arch Virol. 1987;94(1\u20132):97\u2013107.","journal-title":"Arch Virol"},{"issue":"8","key":"1483_CR31","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1128\/JCM.43.8.4229-4233.2005","volume":"43","author":"JG Alamares","year":"2005","unstructured":"Alamares JG, Li J, Iorio RM. Monoclonal antibody routinely used to identify avirulent strains of Newcastle disease virus binds to an epitope at the carboxy terminus of the hemagglutinin-neuraminidase protein and recognizes individual mesogenic and velogenic strains. J Clin Microbiol. 2005;43(8):4229\u201333.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1483_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0165-022X(98)00037-2","volume":"38","author":"PT Gomme","year":"1999","unstructured":"Gomme PT, Stanton PG, Hearn MT. Evaluation of a pepscan approach to identify epitopes recognised by anti-hTSH monoclonal antibodies. J Biochem Biophys Methods. 1999;38(1):53\u201370.","journal-title":"J Biochem Biophys Methods"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-020-01483-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-020-01483-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-020-01483-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T20:10:50Z","timestamp":1610223050000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-020-01483-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1483"],"URL":"https:\/\/doi.org\/10.1186\/s12985-020-01483-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-76059\/v1","asserted-by":"object"}]},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"14 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Animal Care and Use Committee of Northwest A&F University, China, and were conducted in accordance with guidelines established by the Chinese Committee for Animal Experiments (Approval No. 2018XN0928121-034).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors consent to publish.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}